Primary bone tumors of the talus

1994 ◽  
Vol 84 (8) ◽  
pp. 379-384 ◽  
Author(s):  
MS Dhillon ◽  
B Singh ◽  
DP Singh ◽  
V Prabhu ◽  
ON Nagi
Keyword(s):  
Giant Cell ◽  
Bone Grafting ◽  
Bone Tumors ◽  
Malignant Tumors ◽  
Cell Tumor ◽  
Benign Neoplasms ◽  
Giant Cell Tumors ◽  
Surgical Ablation ◽  
Primary Bone Tumors ◽  
Primary Bone

A review of 12 cases of bony tumors involving the talus is presented. Giant cell tumor was the most common tumor. Malignant tumors should be treated by surgical ablation followed by chemotherapy. There are good results after excision or curettage and bone grafting in the treatment of benign neoplasms. Giant cell tumors, if diagnosed early, can be treated by curettage and bone grafting, but if there is talar collapse, a talectomy can be performed.

Giant Cell Tumor of the Metatarsal

Foot & Ankle ◽  
1988 ◽  
Vol 8 (4) ◽  
pp. 223-226 ◽  
Author(s):  
Thomas P. Burns ◽  
Mark Weiss ◽  
Mark Snyder ◽  
Clark N. Hopson
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
En Bloc Resection ◽  
Bloc Resection ◽  
Cell Tumor ◽  
Giant Cell Tumors ◽  
En Bloc ◽  
Primary Bone Tumors ◽  
Metatarsal Bones ◽  
Primary Bone

The following is a report of a giant cell tumor of a metatarsal, description of treatment, and review of the literature. Giant cell tumors comprise approximately 5–8% of the primary bone tumors. Metatarsal bones are a very rare primary site of involvement. Clinically aggressive or benign behavior cannot be predicted histologically. Treatment should be aggressive, as in this case where en bloc resection and bone graft were performed. Results were excellent with 4 yr follow-up.

Giant cell tumors in combination with other primary bone tumors

1981 ◽  
Vol 98 (1) ◽  
pp. 1-6 ◽  
Author(s):  
H. J. Ruckstuhl ◽  
E. Morscher ◽  
W. Remagen ◽  
R. Ganz ◽  
X. Beffa
Keyword(s):  
Giant Cell ◽  
Bone Tumors ◽  
Giant Cell Tumors ◽  
Primary Bone Tumors ◽  
Primary Bone

CRYOSURGERY IN THE TREATMENT OF PATIENTS WITH BONE TUMORS

2019 ◽  
Vol 65 (2) ◽  
pp. 165-171
Author(s):  
Aleksey Belyaev ◽  
Georgiy Prokhorov ◽  
Anna Arkhitskaya
Keyword(s):  
Liquid Nitrogen ◽  
Bone Tumors ◽  
Cryogenic Treatment ◽  
Long Term Results ◽  
Bone Lesions ◽  
Giant Cell Tumors ◽  
Primary Bone Tumors ◽  
Circulation Circuit ◽  
Recent Emergence ◽  
Primary Bone

A review of the literature shows that surgical procedures will remain the standard treatment for primary bone tumors. Analysis of studies on the assessment of long-term results shows that additional double cryogenic treatment of the curettage cavity can improve the treatment outcomes of patients with giant cell tumors, dysplastic diseases and some forms of malignant lesions. The traditional execution of the procedure is associated with the open installation of liquid nitrogen in the bone cavity, which requires special skills in handling aggressive refrigerant from the staff and does not exclude complications. In case of multiple metastatic bone lesions, surgical treatment is not indicated. The recent emergence in clinical practice of new equipment with a closed liquid nitrogen circulation circuit inside cryoprobes resumes interest in cryoabla-tion of bone tumor lesions using modern minimally invasive puncture cryotechnology and expanding indications for its use in patients with severe comorbidities.

scholarly journals Management of a Huge Tenosynovial Giant Cell Tumor of the Wrist

2021 ◽  
Author(s):  
Woo Jong Kim ◽  
Sang Mi Lee ◽  
Byungsung Kim ◽  
Jae-Hwi Nho ◽  
Jun Bum Kim ◽  
...  
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Rare Case ◽  
Tendon Sheath ◽  
Cell Tumor ◽  
Benign Neoplasms ◽  
Diffuse Type ◽  
Giant Cell Tumors ◽  
Tenosynovial Giant Cell Tumor

Tenosynovial giant cell tumors (TGCTs) are typically benign neoplasms of the joint, bursa, and tendon sheath. Usually, TGCT presents as a small localized tumor on the hand and wrist. The diffuse-type TGCT is more aggressive and mainly affects large joints such as knees, hips, ankles, and elbows. Diffuse-type TGCT of small joints is rare. To our knowledge, this is a very rare case of a huge diffuse-type TGCT on the wrist. We report a huge TGCT, which grew gradually over 10 years.

scholarly journals Denosumab efficacy in giant cell tumors of the bone - short review

2018 ◽  
Vol 1 (2) ◽  
pp. 109-111
Author(s):  
Cornelia Nitipir ◽  
Ana Maria Popa ◽  
Cristina Orlov-Slavu
Keyword(s):  
Giant Cell ◽  
Bone Tumors ◽  
Systemic Treatment ◽  
Lung Metastases ◽  
Standard Of Care ◽  
Short Review ◽  
Cell Tumor ◽  
Treatment Sequence ◽  
Giant Cell Tumors

Abstract Giant cell tumors of the bone are tumors whose malignant character has long been debated. Lung metastases have been reported in some cases. They usually represent osteolytic, locally aggressive bone tumors for which surgery is the standard of care. Denosumab is the most effective systemic treatment in these cases, but both the timing and the duration are a matter of debate. The aim of this short review was to describe the most important trials that treated patients with this drug and to discuss both advantages and long-term toxicity. It can be concluded from the presented data that the choice of adding denosumab in the treatment sequence of giant cell tumor of the bone has to be taken in a personalized manner for each patient.

scholarly journals Some Cases of Giant-cell Tumors and Bone Tumors mistaken for Giant-cell Tumor by X-ray Appearance

1966 ◽  
Vol 15 (2) ◽  
pp. 180-182
Author(s):  
T. Kitagawa ◽  
Y. Marubayashi ◽  
H. Ogata ◽  
M. Kondo ◽  
E. Mikajiri ◽  
...  
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Bone Tumors ◽  
Cell Tumor ◽  
Giant Cell Tumors ◽  
X Ray

Malignant Giant-cell Tumor of the Parietal Bone: Case Report and Review of the Literature

Neurosurgery ◽  
2001 ◽  
Vol 48 (2) ◽  
pp. 424-429 ◽  
Author(s):  
Jeffrey Leonard ◽  
Murat Gökden ◽  
Michael Kyriakos ◽  
Colin P. Derdeyn ◽  
Keith M. Rich
Keyword(s):  
Giant Cell ◽  
Clinical Presentation ◽  
Paget’S Disease ◽  
Paget's Disease ◽  
Parietal Bone ◽  
Low Grade ◽  
Giant Cell Tumors ◽  
Primary Bone Tumors ◽  
Malignant Giant Cell Tumor ◽  
Primary Bone

Abstract OBJECTIVE AND IMPORTANCE Giant-cell tumors (GCTs) are primary bone tumors that involve long bones in 75 to 90% of patients. They seldom develop in the cranium and are very rare in patients older than 60 years of age. A GCT rarely occurs with Paget's disease; when it does, however, it is most commonly associated with the polyostotic form and tends to involve the craniofacial bones. Pagetic GCTs are less aggressive than GCTs that are not associated with Paget's disease. CLINICAL PRESENTATION We report the case of an 81-year-old woman with a painless left parietal mass and asymptomatic monostotic parietal Paget's disease. INTERVENTION Surgical resection was performed, and histological examination of the lesion demonstrated Paget's disease with a malignant GCT. An incidental, low-grade, small-cell lymphocytic lymphoma also was noted. The patient experienced local recurrence of the malignant GCT and eventually died after developing pulmonary metastases of the malignant GCT. CONCLUSION This case is the first reported example of a patient with a malignant GCT of the cranium associated with monostotic Paget's disease. It provides evidence that not all pagetic GCTs in the cranium are benign, as has been reported.

scholarly journals Spindle cell sarcoma of sphenoid bone

2017 ◽  
Vol 5 (11) ◽  
pp. 5072
Author(s):  
Moorthy N. L. Nimmagadda ◽  
Vithaleswar M. Rao ◽  
Padmaja S. ◽  
Harshini Reddy
Keyword(s):  
Bone Tumors ◽  
Spindle Cell ◽  
Cell Tumor ◽  
Sphenoid Bone ◽  
Ossifying Fibroma ◽  
Spindle Cell Sarcoma ◽  
Cell Sarcoma ◽  
Primary Bone Tumors ◽  
Primary Bone ◽  
The Common

Primary bone tumors involving skull are extremely rare and they constitute 0.8% of all bone tumors. The common tumors that are seen in skull base include fibrous dysplasia, giant cell tumor, chordoma, ossifying fibroma, angiosarcoma. We report a rare case of spindle cell sarcoma arising from right sphenoid bone in a 70-year-old male which presented as unilateral defective vision with mild proptosis.

scholarly journals Early Outcomes of Reverse Shoulder Arthroplasty for Tumors of the Humerus

2015 ◽  
Vol 22 (2) ◽  
pp. 25-30
Author(s):  
V. Yu Karpenko ◽  
V. A Derzhavin ◽  
A. V Bukharov ◽  
T. V Danilova ◽  
M. S Andreev
Keyword(s):  
Bone Tumors ◽  
Proximal Humerus ◽  
Functional Result ◽  
Malignant Tumors ◽  
Reverse Shoulder Arthroplasty ◽  
Functional Results ◽  
Social Adaptation ◽  
Primary Bone Tumors ◽  
Primary Bone ◽  
Group 2

At present in 90% of patients with malignant tumors of long bones and large joints the organ-saving intervention - oncologic joint replacement can be performed. The risk of complications after such operations on the upper extremity is low however the adequate functional results can not be achieved. The analysis and evaluation of oncologic and functional results after application of anatomic (group 1, n=28) and reverse (group 2, n=14) shoulder prostheses in patients with proximal humerus tumors was performed. Mean age of patients made up 32±4 and 38±3 years in the 1st and 2nd groups, respectively. Primary bone tumors were diagnosed in 19 (68%) patients from the 1st and 12 (86%) patients from the 2nd group. Mean follow up period was 42 months. Progression of the disease at terms from 6 to 14 months was observed in 4 patients with primary malignant bone tumors. Functional result by MSTS scale was 60-80% in 3, 40-60% in 6 and under 40% in 19 patients from the 1st group. In 2nd group functional result ranged from 80 to 100% in 6, from 60 to 80% in 6 and from 40 to 60% in 2 patients. Application of modular reverse prosthesis for the treatment of patients with proximal humerus tumors is a perspective technique as it enables to increase functional result and social adaptation of patients significantly.

scholarly journals Profile of Musculoskeletal Tumor in Saiful Anwar General Hospital Malang from January 2011 until December 2018

2020 ◽  
Vol 16 (2) ◽  
pp. 81
Author(s):  
Istan Irmansyah Irsan ◽  
Satria Pandu Persada Isma ◽  
Abdul Aziz ◽  
Muhammad Hilman Bimadi ◽  
I Gusti Ngurah Arga Aldrian Oktafandi
Keyword(s):  
Soft Tissue ◽  
General Hospital ◽  
Bone Tumor ◽  
Bone Tumors ◽  
Malignant Tumors ◽  
Soft Tissue Tumors ◽  
Musculoskeletal Tumor ◽  
Primary Bone Tumors ◽  
Musculoskeletal Tumors ◽  
Primary Bone

Abstract: Musculoskeletal tumors are relatively rare, with 0.2%-0.5% of all malignant tumors in all ages. The geographic distribution of musculoskeletal tumors varies significantly around the world. This study aims to describe the musculoskeletal tumor profile in Saiful Anwar General Hospital. All data were obtained from the department of orthopaedic and traumatology database, Saiful Anwar general hospital. Thus, patients who were diagnosed with either bone tumor or soft tissue tumor between January 2011 to December 2018 were selected for the present study. The clinical-pathological conference (CPC) was carried out to ensure the validity of all the registered data. A total of 577 patients with tumors from January 2011 to December 2018 was obtained. Out of all the cases, 439 (76%) cases are bone tumors, and the remaining 138 (24%) cases are soft tissue tumors. The most frequent locations of the musculoskeletal tumors are the long bones of the thigh and lower leg. This study shows an increasing trend in musculoskeletal tumors incidence, despite decreasing numbers in several years. This result goes along with a rising trend in malignancy cases with a higher amount compared to the benign one. Moreover, MBD and osteosarcoma were found to be the most common tumor and primary bone tumors, respectively. However, the fact that there is some data loss in the study limited the study for a more accurate result.   Keywords: Musculoskeletal tumor; Bone tumor; Osteosarcoma; Malang; East Java

Sign in / Sign up

Export Citation Format

Share Document